Selected research
Market Structure
Global Oxycodone Hydrochloride Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Oxycodone Hydrochloride Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Oxycodone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Oxycodone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oxycodone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Oxycodone Hydrochloride Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oxycodone Hydrochloride Capsules include NAPP PHARMACEUTICALS LIMITED, Allergan, Hikma Pharmaceuticals, Purdue Pharma, Sandoz, Zydus Cadila, Viatris, Lock Pharma and Teva Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Oxycodone Hydrochloride Capsules market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Oxycodone Hydrochloride Capsules and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Oxycodone Hydrochloride Capsules revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Oxycodone Hydrochloride Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.
Oxycodone Hydrochloride Capsules Segment by Company
NAPP PHARMACEUTICALS LIMITED
Allergan
Hikma Pharmaceuticals
Purdue Pharma
Sandoz
Zydus Cadila
Viatris
Lock Pharma
Teva Pharmaceuticals
Oxycodone Hydrochloride Capsules Segment by Type
5mg
10mg
20mg
Oxycodone Hydrochloride Capsules Segment by Application
Clinic
Hospital
Others
Oxycodone Hydrochloride Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Oxycodone Hydrochloride Capsules in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oxycodone Hydrochloride Capsules industry.
Chapter 3: Detailed analysis of Oxycodone Hydrochloride Capsules companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oxycodone Hydrochloride Capsulesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 10mg
- 20mg
Applications
- Clinic
- Hospital
- Others
Companies covered
- NAPP PHARMACEUTICALS LIMITED
- Allergan
- Hikma Pharmaceuticals
- Purdue Pharma
- Sandoz
- Zydus Cadila
- Viatris
- Lock Pharma
- Teva Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Oxycodone Hydrochloride Capsules Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 5mg
- 1.2.3 10mg
- 1.2.4 20mg
- 1.3 Market Analysis by Application
- 1.3.1 Global Oxycodone Hydrochloride Capsules Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Oxycodone Hydrochloride Capsules Growth Trends by Region
- 1.5.1 Global Oxycodone Hydrochloride Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Oxycodone Hydrochloride Capsules Market Size by Region (2021-2026)
- 1.5.3 Oxycodone Hydrochloride Capsules Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Oxycodone Hydrochloride Capsules Market Dynamics
- 2.1 Oxycodone Hydrochloride Capsules Industry Trends
- 2.2 Oxycodone Hydrochloride Capsules Industry Drivers
- 2.3 Oxycodone Hydrochloride Capsules Industry Opportunities and Challenges
- 2.4 Oxycodone Hydrochloride Capsules Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Oxycodone Hydrochloride Capsules Revenue by Company (2021-2026)
- 3.2 Global Oxycodone Hydrochloride Capsules Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Oxycodone Hydrochloride Capsules Key Company Head office and Area Served
- 3.4 Global Oxycodone Hydrochloride Capsules Company, Product Type & Application
- 3.5 Global Oxycodone Hydrochloride Capsules Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Oxycodone Hydrochloride Capsules Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Oxycodone Hydrochloride Capsules Players Market Share by Revenue in 2025
- 3.6.3 2025 Oxycodone Hydrochloride Capsules Tier 1, Tier 2, and Tier 3
4 Oxycodone Hydrochloride Capsules Market by Type
- 4.1 Global Oxycodone Hydrochloride Capsules Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Oxycodone Hydrochloride Capsules Market Size by Type (2021-2032)
- 4.3 Global Oxycodone Hydrochloride Capsules Market Size Share by Type (2021-2032)
5 Oxycodone Hydrochloride Capsules Market by Application
- 5.1 Global Oxycodone Hydrochloride Capsules Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Oxycodone Hydrochloride Capsules Market Size by Application (2021-2032)
- 5.3 Global Oxycodone Hydrochloride Capsules Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 NAPP PHARMACEUTICALS LIMITED
- 6.1.1 NAPP PHARMACEUTICALS LIMITED Company Information
- 6.1.2 NAPP PHARMACEUTICALS LIMITED Business Overview
- 6.1.3 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Capsules Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Capsules Product Portfolio
- 6.1.5 NAPP PHARMACEUTICALS LIMITED Recent Developments
- 6.2 Allergan
- 6.2.1 Allergan Company Information
- 6.2.2 Allergan Business Overview
- 6.2.3 Allergan Oxycodone Hydrochloride Capsules Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Allergan Oxycodone Hydrochloride Capsules Product Portfolio
- 6.2.5 Allergan Recent Developments
- 6.3 Hikma Pharmaceuticals
- 6.3.1 Hikma Pharmaceuticals Company Information
- 6.3.2 Hikma Pharmaceuticals Business Overview
- 6.3.3 Hikma Pharmaceuticals Oxycodone Hydrochloride Capsules Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Hikma Pharmaceuticals Oxycodone Hydrochloride Capsules Product Portfolio
- 6.3.5 Hikma Pharmaceuticals Recent Developments
- 6.4 Purdue Pharma
- 6.4.1 Purdue Pharma Company Information
- 6.4.2 Purdue Pharma Business Overview
- 6.4.3 Purdue Pharma Oxycodone Hydrochloride Capsules Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Purdue Pharma Oxycodone Hydrochloride Capsules Product Portfolio
- 6.4.5 Purdue Pharma Recent Developments
- 6.5 Sandoz
- 6.5.1 Sandoz Company Information
- 6.5.2 Sandoz Business Overview
- 6.5.3 Sandoz Oxycodone Hydrochloride Capsules Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Sandoz Oxycodone Hydrochloride Capsules Product Portfolio
- 6.5.5 Sandoz Recent Developments
- 6.6 Zydus Cadila
- 6.6.1 Zydus Cadila Company Information
- 6.6.2 Zydus Cadila Business Overview
- 6.6.3 Zydus Cadila Oxycodone Hydrochloride Capsules Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Zydus Cadila Oxycodone Hydrochloride Capsules Product Portfolio
- 6.6.5 Zydus Cadila Recent Developments
- 6.7 Viatris
- 6.7.1 Viatris Company Information
- 6.7.2 Viatris Business Overview
- 6.7.3 Viatris Oxycodone Hydrochloride Capsules Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Viatris Oxycodone Hydrochloride Capsules Product Portfolio
- 6.7.5 Viatris Recent Developments
- 6.8 Lock Pharma
- 6.8.1 Lock Pharma Company Information
- 6.8.2 Lock Pharma Business Overview
- 6.8.3 Lock Pharma Oxycodone Hydrochloride Capsules Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Lock Pharma Oxycodone Hydrochloride Capsules Product Portfolio
- 6.8.5 Lock Pharma Recent Developments
- 6.9 Teva Pharmaceuticals
- 6.9.1 Teva Pharmaceuticals Company Information
- 6.9.2 Teva Pharmaceuticals Business Overview
- 6.9.3 Teva Pharmaceuticals Oxycodone Hydrochloride Capsules Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Teva Pharmaceuticals Oxycodone Hydrochloride Capsules Product Portfolio
- 6.9.5 Teva Pharmaceuticals Recent Developments
7 North America
- 7.1 North America Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 7.2 North America Oxycodone Hydrochloride Capsules Market Size by Type
- 7.2.1 North America Oxycodone Hydrochloride Capsules Market Size by Type (2021-2026)
- 7.2.2 North America Oxycodone Hydrochloride Capsules Market Size by Type (2027-2032)
- 7.2.3 North America Oxycodone Hydrochloride Capsules Market Share by Type (2021-2032)
- 7.3 North America Oxycodone Hydrochloride Capsules Market Size by Application
- 7.3.1 North America Oxycodone Hydrochloride Capsules Market Size by Application (2021-2026)
- 7.3.2 North America Oxycodone Hydrochloride Capsules Market Size by Application (2027-2032)
- 7.3.3 North America Oxycodone Hydrochloride Capsules Market Share by Application (2021-2032)
- 7.4 North America Oxycodone Hydrochloride Capsules Market Size by Country
- 7.4.1 North America Oxycodone Hydrochloride Capsules Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Oxycodone Hydrochloride Capsules Market Size by Country (2021-2026)
- 7.4.3 North America Oxycodone Hydrochloride Capsules Market Size by Country (2027-2032)
- 7.4.4 North America Oxycodone Hydrochloride Capsules Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 8.2 Europe Oxycodone Hydrochloride Capsules Market Size by Type
- 8.2.1 Europe Oxycodone Hydrochloride Capsules Market Size by Type (2021-2026)
- 8.2.2 Europe Oxycodone Hydrochloride Capsules Market Size by Type (2027-2032)
- 8.2.3 Europe Oxycodone Hydrochloride Capsules Market Share by Type (2021-2032)
- 8.3 Europe Oxycodone Hydrochloride Capsules Market Size by Application
- 8.3.1 Europe Oxycodone Hydrochloride Capsules Market Size by Application (2021-2026)
- 8.3.2 Europe Oxycodone Hydrochloride Capsules Market Size by Application (2027-2032)
- 8.3.3 Europe Oxycodone Hydrochloride Capsules Market Share by Application (2021-2032)
- 8.4 Europe Oxycodone Hydrochloride Capsules Market Size by Country
- 8.4.1 Europe Oxycodone Hydrochloride Capsules Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Oxycodone Hydrochloride Capsules Market Size by Country (2021-2026)
- 8.4.3 Europe Oxycodone Hydrochloride Capsules Market Size by Country (2027-2032)
- 8.4.4 Europe Oxycodone Hydrochloride Capsules Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 9.2 China Oxycodone Hydrochloride Capsules Market Size by Type
- 9.2.1 China Oxycodone Hydrochloride Capsules Market Size by Type (2021-2026)
- 9.2.2 China Oxycodone Hydrochloride Capsules Market Size by Type (2027-2032)
- 9.2.3 China Oxycodone Hydrochloride Capsules Market Share by Type (2021-2032)
- 9.3 China Oxycodone Hydrochloride Capsules Market Size by Application
- 9.3.1 China Oxycodone Hydrochloride Capsules Market Size by Application (2021-2026)
- 9.3.2 China Oxycodone Hydrochloride Capsules Market Size by Application (2027-2032)
- 9.3.3 China Oxycodone Hydrochloride Capsules Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 10.2 Asia Oxycodone Hydrochloride Capsules Market Size by Type
- 10.2.1 Asia Oxycodone Hydrochloride Capsules Market Size by Type (2021-2026)
- 10.2.2 Asia Oxycodone Hydrochloride Capsules Market Size by Type (2027-2032)
- 10.2.3 Asia Oxycodone Hydrochloride Capsules Market Share by Type (2021-2032)
- 10.3 Asia Oxycodone Hydrochloride Capsules Market Size by Application
- 10.3.1 Asia Oxycodone Hydrochloride Capsules Market Size by Application (2021-2026)
- 10.3.2 Asia Oxycodone Hydrochloride Capsules Market Size by Application (2027-2032)
- 10.3.3 Asia Oxycodone Hydrochloride Capsules Market Share by Application (2021-2032)
- 10.4 Asia Oxycodone Hydrochloride Capsules Market Size by Country
- 10.4.1 Asia Oxycodone Hydrochloride Capsules Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Oxycodone Hydrochloride Capsules Market Size by Country (2021-2026)
- 10.4.3 Asia Oxycodone Hydrochloride Capsules Market Size by Country (2027-2032)
- 10.4.4 Asia Oxycodone Hydrochloride Capsules Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Type
- 11.2.1 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Application
- 11.3.1 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Country
- 11.4.1 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Oxycodone Hydrochloride Capsules Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst